6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
2m ago	Aviva : Probitas Canada to integrate Volante Canadian team
4m ago	OpenTable Announces Canadian Expansion with New Toronto Office Lease
6m ago	Nanobiotix Announces Pricing of Oversubscribed €85m Global Offering
7m ago	AnorTech to Receive Cash and Equity from Corporate Transaction on the Sarfartoq Rare Earth Project
8m ago	D. Boral Capital Acted as Exclusive Placement Agent to LanzaTech Global, Inc. (Nasdaq:LNZA) in Connection with its $20,000,000 Registered Direct Offering

About

2,446.00JPY+19.50 +0.80%

Closed • Updated at 15:10 GMT+00:00

Market Cap$7.17B

P/E Ratio16.48

Volume1.86M

Beta0.90

RSI50.42

Gross Margin72.52%

Health TechnologyPharmaceuticals: Major

Ono Pharmaceutical Co., Ltd. — investor relations, events, news, and company updates on 6ix.

Latest News

Sinopia Biosciences Announces Target Discovery Collaboration with Ono Pharmaceutical for Rare Metabolic Disorders

Congruence and Ono Pharma Expand Multi-Target Research Partnership with the Addition of Two New Programs

Ono Shares Replay Information for 44th Annual J.P. Morgan Healthcare Conference Presentation

Ono to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical

Community Chat

Ask AI